Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Coyne

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Kidney International|October 10, 2008
Variability of ferritin measurements in chronic kidney disease; implications for iron managementBradley A Ford, Daniel W Coyne, Charles S Eby, et al.
Kidney International|July 30, 2010
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patientsBradley A Ford, Charles S Eby, Mitchell G Scott, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKDDaniel W Coyne, Seth Goldberg, Mark Faber, et al.
Advances in Renal Replacement Therapy|October 29, 2000
Network 12 hepatitis B vaccination quality improvement program: an educational program directed at physicians, staff, and patientsD W Coyne, L F Taylor, S Yelton, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 1999
Leptin elimination in hyperleptinaemic peritoneal dialysis patientsM Landt, C A Parvin, S Dagogo-Jack, et al.
Journal of Nephrology|February 9, 2022
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidenceDaniel W Coyne, Stuart M Sprague, Marc Vervloet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL studyDaniel W Coyne, Dennis L Andress, Michael J Amdahl, et al.
Nephron. Clinical Practice|January 18, 2007
Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patientsGeorges Saab, Daniel O Young, Yekaterina Gincherman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patientsDaniel W Coyne, Marvin Grieff, Shubhada N Ahya, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2004
Sodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safetyBeckie Michael, Daniel W Coyne, Vaughn W Folkert, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Kidney International|October 10, 2008
Variability of ferritin measurements in chronic kidney disease; implications for iron managementBradley A Ford, Daniel W Coyne, Charles S Eby, et al.
Kidney International|July 30, 2010
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patientsBradley A Ford, Charles S Eby, Mitchell G Scott, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKDDaniel W Coyne, Seth Goldberg, Mark Faber, et al.
Advances in Renal Replacement Therapy|October 29, 2000
Network 12 hepatitis B vaccination quality improvement program: an educational program directed at physicians, staff, and patientsD W Coyne, L F Taylor, S Yelton, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 1999
Leptin elimination in hyperleptinaemic peritoneal dialysis patientsM Landt, C A Parvin, S Dagogo-Jack, et al.
Journal of Nephrology|February 9, 2022
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidenceDaniel W Coyne, Stuart M Sprague, Marc Vervloet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL studyDaniel W Coyne, Dennis L Andress, Michael J Amdahl, et al.
Nephron. Clinical Practice|January 18, 2007
Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patientsGeorges Saab, Daniel O Young, Yekaterina Gincherman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patientsDaniel W Coyne, Marvin Grieff, Shubhada N Ahya, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2004
Sodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safetyBeckie Michael, Daniel W Coyne, Vaughn W Folkert, et al.
Pageof 10